Trillium Ag
www.trilliumag.comTrillium Ag is developing a portfolio of RNAi-based biologicals to improve crop protection, health and yield. Our product pipeline is based on the breakthrough RNAi trigger (MV-RNA, US Patent 9,200,276) and nanoparticles for transient or stable trait activation.
Read more
Trillium Ag is developing a portfolio of RNAi-based biologicals to improve crop protection, health and yield. Our product pipeline is based on the breakthrough RNAi trigger (MV-RNA, US Patent 9,200,276) and nanoparticles for transient or stable trait activation.
Read more
Country
Industry
Employees
1-10
Founded
2016
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Founder
Email ****** @****.comPhone (***) ****-****Co - Founder
Email ****** @****.comPhone (***) ****-****Chief Scientist
Email ****** @****.comPhone (***) ****-****
Reach decision makers at Trillium Ag
Free credits every month!
Trillium Ag FAQ
United States
Biotechnology Research
We'll help you understand if Lusha can solve your business needs.
